Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Tandemact

Tandemact 30 mg/2 mg tablets Tandemact 30 mg/4 mg tablets · Abschnitt 4.8 · PDF-Seite 9

HOS-115647 · Präparat HOS-094329

Adverse reaction Frequency of adverse reactions Pioglitazone Glimepiride Tandemact Infections and infestations upper respiratory tract infection common common sinusitis uncommon uncommon Neoplasms benign, malignant and unspecified (including cysts and polyps) bladder cancer uncommon uncommon Blood and lymphatic system disorders changes in haematology1 rare rare Immune system disorders allergic shock2 very rare very rare allergic vasculitis2 very rare very rare hypersensitivity and allergic reactions3 not known not known Metabolism and nutrition disorders hypoglycaemia uncommon appetite increased uncommon Nervous system disorders dizziness common hypo-aesthesia common common headache uncommon insomnia uncommon uncommon Eye disorders visual disturbance4 common uncommon macular oedema not known not known Ear and labyrinth disorders vertigo uncommon Gastrointestinal disorders5 flatulence common vomiting very rare very rare diarrhoea very rare very rare nausea very rare very rare abdominal pain very rare very rare abdominal pressure very rare very rare

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.